Fixed drug eruption after pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b combined vaccine in an infant

被引：2
|
作者：
Savas Erdogan, Sevil [1 ]
Cebeci Kahraman, Filiz [2 ]
机构：
[1] Univ Hlth Sci, Dept Dermatol, Sultan Abdulhamid Han Training & Res Hosp 2, Istanbul, Turkey
[2] Istanbul Medeniyet Univ, Goztepe Prof Dr Suleyman Yalcin City Hosp, Dept Dermatol, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 30卷 / 04期
关键词：
drug-related side effects and adverse reactions; allergy and immunology; clinical medicine; case reports; pediatrics; primary health care; dermatology; public health; ALLERGY; ALUMINUM; NODULES; ECZEMA;
D O I：
10.1136/ejhpharm-2021-002875
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In Turkey, diphtheria-tetanus-acellular pertussis-inactivated poliovirus and Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine has been administered to all children in the second, fourth, sixth and 18th months within the scope of the national vaccination programme. Here we present a rare case of fixed drug eruption (FDE) that occurred as a result of the administration of a pentavalent DTaP-IPV-Hib combined vaccine in a 4-month-old girl. There was no history of taking any other medication before or when the lesion appeared. The lesion responded well to 1 week of topical methylprednisolone aceponate cream application and regressed within 1 week, leaving mild hyperpigmentation. Few cases of FDE have been reported occurring after administration of various vaccines and it is extremely rare in children. To our knowledge, this is the first reported case of FDE developing in an infant after the combined pentavalent DTaP-IPV-Hib vaccine.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China
    Li, Rong Cheng
    Li, Feng Xiang
    Li, Yan Ping
    Hou, Qi Ming
    Li, Chang Gui
    Li, Ya Nan
    Chen, Fu Sheng
    Hu, Xue Zhong
    Su, Wen Bin
    Zhang, Shu Min
    Fang, Han Hua
    Ye, Qiang
    Zeng, Tian De
    Liu, Tao Xuan
    Li, Xiu Bi
    Huang, Yun Neng
    Deng, Man Ling
    Zhang, Yan Ping
    Ortiz, Esteban
    VACCINE, 2011, 29 (10) : 1913 - 1920
  • [22] Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine
    Daley, Matthew F.
    Yih, W. Katherine
    Glanz, Jason M.
    Hambidge, Simon J.
    Narwaney, Komal J.
    Yin, Ruihua
    Li, Lingling
    Nelson, Jennifer C.
    Nordin, James D.
    Klein, Nicola P.
    Jacobsen, Steven J.
    Weintraub, Eric
    VACCINE, 2014, 32 (25) : 3019 - 3024
  • [23] Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
    Klein, Nicola P.
    Abu-Elyazeed, Remon
    Cheuvart, Brigitte
    Janssens, Winnie
    Mesaros, Narcisa
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 809 - 821
  • [24] Adverse effects and sero-responses to an acellular pertussis/diphtheria/tetanus vaccine when combined with Haemophilus influenzae type b vaccine in an accelerated schedule
    Bell, F
    Heath, P
    MacLennan, J
    Shackley, F
    Shearstone, N
    Diggle, L
    Thornton, C
    Griffiths, H
    Moxon, ER
    Finn, A
    EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (04) : 329 - 336
  • [25] Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine
    Halperin, Scott A.
    Tapiero, Bruce
    Dionne, Marc
    Meekison, William
    Diaz-Mitoma, Francisco
    Zickler, Paul
    Rubin, Earl
    Embree, Joanne
    Bhuyan, Prakash
    Lee, Andrew
    Li, Minran
    Tomovici, Antigona
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (01) : 73 - 80
  • [26] Adverse effects and sero-responses to an acellular pertussis/diphtheria/tetanus vaccine when combined with Haemophilus influenzae type b vaccine in an accelerated schedule
    F. Bell
    P. Heath
    J. MacLennan
    F. Shackley
    N. Shearstone
    L. Diggle
    C. Thornton
    H. Griffiths
    E. R. Moxon
    A. Finn
    European Journal of Pediatrics, 1999, 158 : 329 - 336
  • [27] The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination
    Goldblatt, D
    Richmond, P
    Millard, E
    Thornton, C
    Miller, E
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 538 - 541
  • [28] Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine
    Meriste, Sirli
    Lutsar, Irja
    Tamm, Eda
    Willems, Paul
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (05) : 350 - 356
  • [29] Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents
    Bégué, PC
    Grimprel, EM
    Giovannangeli, MD
    Abitbol, VI
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (09) : 804 - 809
  • [30] Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation
    Bell, F
    Martin, A
    Blondeau, C
    Thornton, C
    Chaplais, J
    Finn, A
    ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (04) : 298 - 303
12345